Status:
COMPLETED
MK-0431/ONO-5435 Phase III Clinical Trial - Insulin Add-on Study for Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
This Phase III clinical trial will examine the efficacy, safety, and tolerability of the addition of MK-0431/ONO-5435 to Japanese patients with Type 2 Diabetes Mellitus who have inadequate glycemic co...
Eligibility Criteria
Inclusion
- Japanese Patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on diet/exercise therapy and insulin monotherapy
Exclusion
- Patients with Type 1 Diabetes Mellitus
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT00854035
Start Date
February 1 2009
Last Update
June 14 2012
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Chugoku Region
Chugoku, Japan
2
Chubu Region
Chūbu, Japan
3
Hokuriku Region
Hokuriku, Japan
4
Kanto Region
Kanto, Japan